about
The epigenetic landscape of acute myeloid leukemiaThe transposase domain protein Metnase/SETMAR suppresses chromosomal translocationsDownstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implicationsTribbles homolog 2 inactivates C/EBPalpha and causes acute myelogenous leukemiaALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcomeReceptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cellsStem Cell Modeling of Core Binding Factor Acute Myeloid LeukemiaRare Cytogenetic Abnormalities and Alteration of microRNAs in Acute Myeloid Leukemia and Response to TherapyMolecular landscape of acute myeloid leukemia in younger adults and its clinical relevancePediatric AML: From Biology to Clinical ManagementCurrent concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemiaStructural and dynamic studies of the transcription factor ERG reveal DNA binding is allosterically autoinhibitedTET2 gene mutation is unfavorable prognostic factor in cytogenetically normal acute myeloid leukemia patients with NPM1+ and FLT3-ITD - mutations.ZFP36L1 promotes monocyte/macrophage differentiation by repressing CDK6FLT3 tyrosine kinase inhibitors in acute myeloid leukemia: clinical implications and limitationsThe Kasumi-1 cell line: a t(8;21)-kit mutant model for acute myeloid leukemiaGenomic and epigenomic landscapes of adult de novo acute myeloid leukemia.Epigenetic Guardian: A Review of the DNA Methyltransferase DNMT3A in Acute Myeloid Leukaemia and Clonal Haematopoiesis.Array CGH in human leukemia: from somatics to genetics.Clinical and laboratory features of seven patients with acute myeloid leukemia (AML)-M2/M3 and elevated myeloblasts and abnormal promyelocytes.Genetic tests to evaluate prognosis and predict therapeutic response in acute myeloid leukemia.Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells.Retroviral insertional mutagenesis identifies Zeb2 activation as a novel leukemogenic collaborating event in CALM-AF10 transgenic mice.Requirement for Parp-1 and DNA ligases 1 or 3 but not of Xrcc1 in chromosomal translocation formation by backup end joining.AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec.Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia.Prognostic impact of RAS mutations in patients with myelodysplastic syndrome.Dasatinib impairs long-term expansion of leukemic progenitors in a subset of acute myeloid leukemia cases.MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment.Decreased SFRP2 expression is associated with intermediate and poor karyotypes in de novo acute myeloid leukemiaGeneration of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing.Development of a multi-step leukemogenesis model of MLL-rearranged leukemia using humanized miceDasatinib inhibits the growth of molecularly heterogeneous myeloid leukemias.Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase.MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia.Constitutive activation of the Wnt/beta-catenin signalling pathway in acute myeloid leukaemia.Trisomy 14 as a sole chromosome abnormality is associated with older age, a heterogenous group of myeloid neoplasms with dysplasia, and a wide spectrum of disease progression.Identification and characterization of genes involved in embryonic crystal cell formation during Drosophila hematopoiesis.Chromosome-wide aneuploidy study (CWAS) in workers exposed to an established leukemogen, benzene.Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype.
P2860
Q21284742-6910A685-7D86-41B1-8B44-0E5EEE668C49Q24338398-DDA375EF-8482-4B9B-9C59-F881F3EF88FAQ24617091-C32F96FB-EC95-4DA4-8C15-4518857B04EBQ24627314-56007633-1D0A-4E56-8D39-7643D8B064C0Q24657877-D796C93F-7E2F-4352-B927-3CA2E3BD2F38Q26740953-7D6505AA-0212-412A-B5AF-9980330499B3Q26765858-5BCA67F8-9768-47D5-A3A3-8B53C1882860Q26771425-E74D6BAF-11A4-4FE1-8E42-E0A7F26150BDQ26776393-7308599A-B9B7-463E-9DB4-94298766AC91Q26799773-8EB5014A-0435-424C-BAE6-855BA033E74CQ27025242-3B15950D-CF3A-46A2-9B16-CF9408F29582Q27679276-B674562A-505D-42F6-AC13-C6EE4765A6CBQ27853009-E97EB4B6-F853-4662-AEC5-25F6DA77972FQ28114783-CF8DCCCF-AD5F-4824-801E-3B17FF40E545Q28289859-9DB011C7-A792-4AE9-AEDF-82CA4C73C3B6Q28300267-6534EAAB-C16D-4C7C-8363-26C3A204604EQ29615735-1D287183-ABB9-4E13-BD91-523D800C452AQ30235316-E5BC926E-F9C3-4B7C-ABB1-A3BBDF3025F3Q33397024-9702A4EE-BBA0-4986-94ED-509FE5A308D0Q33420399-E7EEA9A2-2959-4556-99F6-605E4D5FBBEEQ33555627-8BB60B2A-AD7B-4F14-98C0-26B28E057E1AQ33556931-0D79336D-2272-4414-808C-D2E411408E83Q33677450-9B3900C9-0682-4FDA-B33B-2F00DA649673Q33698679-192C9E71-3AB0-428A-890E-2F9ED1AD3A1EQ33762738-76223C7A-F789-47B7-AB2D-4E6A2FDF89C9Q33795018-9455C851-B91C-422E-AB11-98EF83D5EB37Q33871210-C0064AA8-B53F-43E9-BE00-CBD2A05E2B52Q34109861-DDB89A70-BECD-45D9-B4EB-093FA30BE899Q34113855-B3B2CDC4-D601-4E77-BAB6-30B2393D0F2AQ34121336-A29FC736-9BB5-42A4-A068-6BB09B34F3EEQ34160912-B3C2E624-438F-4891-9D9B-B81E56E15142Q34321077-F6CB343F-971D-4975-8908-627E13127B4FQ34335004-46AA0E41-7854-41E8-ACF6-8E52E4E8251BQ34346611-EAB645C0-6961-445D-BE6E-D03637FD2D70Q34386922-DE7C174D-A2BA-4B7B-896A-2B677488F08FQ34398498-9D29192C-F3F7-40A8-A3E2-E88831B982F1Q34557574-B7640A01-A2E0-4BE8-B6BA-4AAFABEE93B8Q34567142-2F6E5CCD-F86F-434D-8CC7-0BCACA2E9385Q34734098-16BF00B2-BADB-402D-B09F-0AE1AA48CCA5Q34754867-7645DD6F-BA3B-4F12-BB39-975D84AB7AC8
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Genetics of myeloid leukemias.
@ast
Genetics of myeloid leukemias.
@en
Genetics of myeloid leukemias.
@nl
type
label
Genetics of myeloid leukemias.
@ast
Genetics of myeloid leukemias.
@en
Genetics of myeloid leukemias.
@nl
prefLabel
Genetics of myeloid leukemias.
@ast
Genetics of myeloid leukemias.
@en
Genetics of myeloid leukemias.
@nl
P1476
Genetics of myeloid leukemias.
@en
P2093
D Gary Gilliland
Louise M Kelly
P304
P356
10.1146/ANNUREV.GENOM.3.032802.115046
P577
2002-04-15T00:00:00Z